-
Je něco špatně v tomto záznamu ?
The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids
Y. Petrenko, E. Syková, Š. Kubinová,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, přehledy
NLK
BioMedCentral
od 2010-03-01
BioMedCentral Open Access
od 2010
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010 do Před 1 rokem
PubMed Central
od 2010
Europe PubMed Central
od 2010
ProQuest Central
od 2015-01-01
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
Medline Complete (EBSCOhost)
od 2010-01-01
Health & Medicine (ProQuest)
od 2015-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
Springer Nature OA/Free Journals
od 2010-03-01
- MeSH
- buněčné kultury MeSH
- buněčné sféroidy cytologie metabolismus transplantace MeSH
- cytokiny metabolismus MeSH
- kardiovaskulární nemoci patologie terapie MeSH
- lidé MeSH
- mezibuněčné signální peptidy a proteiny metabolismus MeSH
- multipotentní kmenové buňky cytologie metabolismus MeSH
- viabilita buněk MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The efficiency of clinical trials involving transplantation of multipotent mesenchymal stromal cells (MSCs) is often insufficient due to harsh conditions present within the target tissue including hypoxia, low nutrient supply as well as inflammatory reactions. This indicates the necessity for optimization of cell-based therapy approaches which might include either modification of the cell manufacturing process or specific cell pretreatment procedures prior to transplantation. Recent reports confirm evidence that the aggregation of MSCs into three-dimensional (3D) multicellular spheroids results in enhancement of the overall therapeutic potential of cells, by improving the anti-inflammatory and angiogenic properties, stemness and survival of MSCs after transplantation. Such an MSCs spheroid generation approach may open new opportunities for the enlargement of MSCs applications in clinical research and therapy. However, the unification and optimization of 3D spheroid generation techniques, including the selection of appropriate clinical-grade culture conditions and methods for their large-scale production, are still of great importance. The current review addresses questions regarding therapeutic-associated properties of 3D multicellular MSCs spheroids in vitro and during preclinical animal studies, with special attention to the possibilities of translating these research achievements toward further clinical manufacturing and applications.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010634
- 003
- CZ-PrNML
- 005
- 20180419145711.0
- 007
- ta
- 008
- 180404s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13287-017-0558-6 $2 doi
- 035 __
- $a (PubMed)28446248
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Petrenko, Yuriy $u Department of Biomaterials and Biophysical Methods, Institute of Experimental Medicine AS CR v. v. i, Vídeňská 1083, 14220, Prague 4-Krč, Czech Republic. yuri.petrenko@biomed.cas.cz.
- 245 14
- $a The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids / $c Y. Petrenko, E. Syková, Š. Kubinová,
- 520 9_
- $a The efficiency of clinical trials involving transplantation of multipotent mesenchymal stromal cells (MSCs) is often insufficient due to harsh conditions present within the target tissue including hypoxia, low nutrient supply as well as inflammatory reactions. This indicates the necessity for optimization of cell-based therapy approaches which might include either modification of the cell manufacturing process or specific cell pretreatment procedures prior to transplantation. Recent reports confirm evidence that the aggregation of MSCs into three-dimensional (3D) multicellular spheroids results in enhancement of the overall therapeutic potential of cells, by improving the anti-inflammatory and angiogenic properties, stemness and survival of MSCs after transplantation. Such an MSCs spheroid generation approach may open new opportunities for the enlargement of MSCs applications in clinical research and therapy. However, the unification and optimization of 3D spheroid generation techniques, including the selection of appropriate clinical-grade culture conditions and methods for their large-scale production, are still of great importance. The current review addresses questions regarding therapeutic-associated properties of 3D multicellular MSCs spheroids in vitro and during preclinical animal studies, with special attention to the possibilities of translating these research achievements toward further clinical manufacturing and applications.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kardiovaskulární nemoci $x patologie $x terapie $7 D002318
- 650 _2
- $a buněčné kultury $7 D018929
- 650 _2
- $a viabilita buněk $7 D002470
- 650 _2
- $a cytokiny $x metabolismus $7 D016207
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mezibuněčné signální peptidy a proteiny $x metabolismus $7 D036341
- 650 _2
- $a multipotentní kmenové buňky $x cytologie $x metabolismus $7 D039902
- 650 _2
- $a buněčné sféroidy $x cytologie $x metabolismus $x transplantace $7 D018874
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Syková, Eva $u Department of Neuroscience, Charles University, Second Faculty of Medicine, V Uvalu 84, 15006, Prague, Czech Republic.
- 700 1_
- $a Kubinová, Šárka $u Department of Biomaterials and Biophysical Methods, Institute of Experimental Medicine AS CR v. v. i, Vídeňská 1083, 14220, Prague 4-Krč, Czech Republic.
- 773 0_
- $w MED00188821 $t Stem cell research & therapy $x 1757-6512 $g Roč. 8, č. 1 (2017), s. 94
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28446248 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180419145812 $b ABA008
- 999 __
- $a ok $b bmc $g 1288119 $s 1007446
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 8 $c 1 $d 94 $e 20170426 $i 1757-6512 $m Stem cell research & therapy $n Stem Cell Res Ther $x MED00188821
- LZP __
- $a Pubmed-20180404